Stock AIM AIM IMMUNOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus AIM ImmunoTech Inc.

Equities

AIM

US00901B1052

Delayed Nyse
Other stock markets
 10:46:25 2024-06-04 am EDT 		5-day change 1st Jan Change
0.38 USD +7.65% Intraday chart for AIM ImmunoTech Inc. +9.11% -13.18%
May. 16 Transcript : AIM ImmunoTech Inc., Q1 2024 Earnings Call, May 16, 2024
May. 15 AIM ImmunoTech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on AIM ImmunoTech Inc.

Price target over the last 5 years

History of analyst recommendation changes

17ccef4ef04d.64OKjsU-_bEgAApGclZNP4UBzsThU0jnY2p7owVF6X8.qLHdu_1OyYVUbmsWSx41Dc9vj52vMT3UUiIY-TYWpRiOs9P-mlDP92FmMg~b8d37cd2b2c083d66ed096c1dde6eeb4

Analyst Recommendations on AIM ImmunoTech Inc.

Maxim Group Adjusts AIM ImmunoTech Price Target to $3 From $5, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.353 USD
Average target price
3.583 USD
Spread / Average Target
+915.11%
High Price Target
5.25 USD
Spread / Highest target
+1,387.25%
Low Price Target
2 USD
Spread / Lowest Target
+466.57%

Consensus detail

Consensus revision (last 18 months)

Analysts covering AIM ImmunoTech Inc.

Maxim

Ratings for AIM ImmunoTech Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. AIM Stock
  4. Consensus AIM ImmunoTech Inc.